Spondyloarthropathies: Tofacitinib shows promise in PsA trials
- PMID: 29255210
- DOI: 10.1038/nrrheum.2017.183
Spondyloarthropathies: Tofacitinib shows promise in PsA trials
Comment on
-
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors.N Engl J Med. 2017 Oct 19;377(16):1525-1536. doi: 10.1056/NEJMoa1615977. N Engl J Med. 2017. PMID: 29045207 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials